Biochemical background of trimethoprim-sulphamethoxazole.
D062365:Aminobenzoates / Q000378:metabolism; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects / Q000378:metabolism; D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D005492:Folic Acid / Q000096:biosynthesis; D005493:Folic Acid Antagonists / Q000494:pharmacology; D006801:Humans; D051379:Mice; D008826:Microbial Sensitivity Tests; D010961:Plasmodium / Q000187:drug effects; D011512:Proteus Infections / Q000188:drug therapy; D011514:Proteus vulgaris; D011743:Pyrimidines / Q000494:pharmacology*; D013420:Sulfamethoxazole / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D013763:Tetrahydrofolates / Q000378:metabolism; D013940:Thymidylate Synthase / Q000378:metabolism; D014295:Trimethoprim / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use
D062365:Aminobenzoates; D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D013763:Tetrahydrofolates; D005492:Folic Acid; D014295:Trimethoprim; D013940:Thymidylate Synthase; D013420:Sulfamethoxazole